Absci (ABSI) Cash & Current Investments (2020 - 2026)

Absci (ABSI) reported Cash & Current Investments of $125.7 million for Q1 2026, down 6.18% on a YoY basis from $134.0 million in Q1 2025, and down 12.88% sequentially from $144.3 million in Q4 2025.

Absci (ABSI) Cash & Current Investments (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Cash & Current Investments data on file, last reported at $125.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 6.18% year-over-year to $125.7 million; the trailing twelve-month figure through Mar 2026 stood at $125.7 million (down 6.18% YoY), and the FY2025 full-year result was $144.3 million, up 28.35% from the prior year.
  • Cash & Current Investments retreated to $125.7 million in Q1 2026, from $144.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $226.0 million in Q1 2022 to a low of $50.0 million in Q2 2022.
  • A 5-year average of $136.6 million and a median of $134.0 million in 2025 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments tumbled 49.72% in 2022 and surged 149.16% in 2023, its largest moves.
  • Tracing ABSI's Cash & Current Investments over 5 years: stood at $164.4 million in 2022, then sank by 40.61% to $97.7 million in 2023, then gained by 15.12% to $112.4 million in 2024, then increased by 28.35% to $144.3 million in 2025, then retreated by 12.88% to $125.7 million in 2026.
  • Business Quant data shows ABSI's Cash & Current Investments at $125.7 million in Q1 2026, $144.3 million in Q4 2025, and $152.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Absci 1.17 Bn 1.05 Bn - 125.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 125.71 Mn
Dec 31, 2025 144.29 Mn
Sep 30, 2025 152.48 Mn
Jun 30, 2025 117.46 Mn
Mar 31, 2025 133.98 Mn
Dec 31, 2024 112.43 Mn
Sep 30, 2024 127.07 Mn
Jun 30, 2024 145.25 Mn
Mar 31, 2024 161.54 Mn
Dec 31, 2023 97.66 Mn
Sep 30, 2023 113.48 Mn
Jun 30, 2023 124.59 Mn
Mar 31, 2023 144.26 Mn
Dec 31, 2022 164.43 Mn
Sep 30, 2022 181.31 Mn
Jun 30, 2022 50.00 Mn
Mar 31, 2022 226.00 Mn
Dec 31, 2021 252.57 Mn
Sep 30, 2021 279.26 Mn
Jun 30, 2021 99.45 Mn